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ABSTRACT
Ginseng is a traditional herbal medicine
which is highly appreciated by the people of China, Korea
and Japan. It has been found to possess many pharmacological
effects. Of particular interests in modern day context
is its anti-stress effect.
In the present study, total ginseng saponin
fraction was administered to rats intraperitoneally in
chronic doses and chronic-acute doses. It has been able to
confirm that the total ginseng saponin fraction increased
serum corticosterone level by 1.6 fold. However, this change
seemed to be significant only when chronic-acute doses of
ginseng saponin were administered over 3 days. It was further
observed that ginseng saponin could change the distribution of
corticosterone in the brain after chronic-acute treatment.
There was a decrease in pituitary corticosterone level by
1.8 fold, and an increase in cerebrum corticosterone level
by 1.7 fold. The results are statistically significant.
Hypothalamus corticosterone level was not affected. However,
the above parameters remained unchanged in the chronic group
after ginseng treatment, indicating the acute effect of
ginseng saponin on the rats.
Nevertheless, in the treated animals including
the chronic group and chronic-acute group, total ginseng
saponin could augment the response of adrenal gland''in vitro
to different doses of ACTH over 100-fold range. Also, the
binding capacity of liver binding protein was enhanced in
both treated groups. The binding affinity was the same
between control and treated animals. From these results,
the chronic effect of ginseng saponin is demonstrated.
Binding capacity and affinity of serum CBG
(corticosteroid-binding globulin) was also studied, but
no difference was observed between control and treated
animals in both groups.
These findings suggest that ginseng saponin
can sensitize the pituitary-adrenal axis as a contribution
to prepare the rat against stress.
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Life consists of a series of micro and macro adap-
tations to a constantly changing internal and external
environment. Life is a continuous confrontation with differen
stress. The body is consistently withstanding various kinds
of chemical, physical and emotional stressors, such as shock,
restraint, isolation, agression, cold, heat, hunger, tissue
damage, etc. When the individual is subjected to chronic
stress or recurrent stress, a number of diverse noxious
effects may begin to manifest themselves and the body func-
tion may be altered reversibly or irreversibly.
Ginseng is well known among the Chinese people
and other culturally related ethnic groups in East Asian
countries since ancient time. It has been used traditionally
for its.anti-stress action. However, the scientific rationale
of this ginseng action remained unknown although many studies
and observations suggested the possibility that ginseng
might simply reduce mortality through its influence upon
stress mechanism. It is not until the middle of the 20th
century that ginseng and glucocorticoid were first correlated
The present study attempts to explore the action
of ginseng on the pituitary--adrenal axis. The present data
are not intended to afford a conclusion of the ginseng
effects through glucocorticoid action, they are rather
problems in a condition that can be broadly described as
2intended to document a distribution pattern of corticoste-
rone in the rat after ginseng treatment. This constitutes''.
preliminary step to gain more insight in the action mecha-
nism of ginseng, with special-reference to--its anti--stress
property.
In the present study, attention has been focused
on the corticosterone level in serum and pituitary as well
as other parts of the brain. Studies are extended to the
corticosterone binding proteins in liver and serum. As a
further effort to evaluate the ginseng effect on the adreno-
cortical system, steroidogenesis in the adrenals is also
investigated.
1.1. GINSENG IN CHINESE MEDICINE:
Ginseng is one of the medicinal plant products
discovered by the Chinese people since prehistoric times.
In their struggle with hunger and diseases, the early people
in North China found that the fleshy` roots in the forest
shades could give strength and vigor. While this special
property of ginseng is passed on by word of mouth, certain
myths were developed mainly influenced by the doctrine of
signature. It was therefore suggested that ginseng root
is a miniscule human form absorbing the essence from the
earth, hence its tonic property. The first written account
of ginseng appeared in the Shen Nung Pents'ao Ching
the first Chinese pharmacopoeia accredited
( 神 農 本 草 經 )
3to the Divine Plowman (Shen-Nung 神 農 ).The authorship
of this pharmacopoeia remained obscure, it was probably
first published in late Han dynasty (2-300 A.D.). In this
work, the description of ginseng is short and concise. It
consists of 44 words which give the name ginseng with two
synonyms, the taste and property, the habitat, and medicinal
function of the drug:
Ginseng is also called Jen-hsien 人 行
Man Gag), or Kuei-kai ( 鬼 书 Demon's Umbrella). It tastes
sweetish, and its property is slightly cooling. It grows in
the gorges of the mountains. It is used for repairing the
five viscera, quietening the spirit, curbing the emotion,
stopping agitation, removing noxious influence, brightening
the eyes, enlightening the mind, and increasing the wisdom.
Continuous use leads one to longevity with light weight.
(Hu, 1977).
The term ginseng stands for two Chinese
ideograms （ 人 参 ） The charact er Jen (gin, 人 stands
for man, and Shen (seng, 参 ) stands for essence. This refers
to the more or less human. form of the root and its tonic
property.
In Shang Han-Lun by Chang Chung-Ching
(_150-219 A.D.), the first practical guide to clinical Chinese
medicine, the use of ginseng was incorporated in several
prescriptions. The knowledge in ginseng accumulated with the
years. In the books published in Liang Dynasty( 梁 502-555
4A.D.), such as Pents'ao Chi Chu ( 本 草 集 注 ) and Ming I
Pieh Lu ( 名 医 别 录 ） the centers of production, the time
for gathering the roots, and the morphological characters
of the plants were given. By Tang Dynasty( 唐 618-905 A.D.),
ginseng was an article of tribute presented to the royalty.
In Sung Dynasty( 960-1126 A.D.), the use of ginseng
became privilege of the rich. As time went on the demand
for ginseng gradually increased while the production decrea-
sed. In Ming dynasty, Pents'ao Kang Mu
( 本 草 钢 目 )
by Li Shi Chen was
published (1596), the properties and clinical functions of
ginseng were fully described.
1.2. BOTANICAL CHARACTERISTICS OF GINSENG: (Hu, 1977)
The ginseng plant belongs to the Araliaceae
family. The commercial product of ginseng comes from two
separate species they are Panax ginseng C.A*. Meyer, which
is the source of the Chinese, Korean and Japanese ginseng
and Panax •quinquefolius L., which is the source of American
ginseng.
Morphologically, ginseng is a perennial herb with
short underground stem (rhizome) associated with a fleshy
white root, a single annual stem bearing a whorl of palmately
compound leaves, and a terminal simple umbel of small
5-merous flowers. The flowers are soon followed by pea-
sized fruits developed from inferior ovaries. The fruits
are red when ripe.
宋
5Ginseng plants begin to flower at the age of three
or four. One common variation that occurs in ginseng plants
is that the plants sometimes produce perfect flowers, and
sometimes produce separate staminate and pistillate flowers
instead. A plant.that has perfect flowers will produce
seed. The ginseng plant reproduces itself in nature by
seed only. Another rarity in the ginseng plant that is
occasionally encountered is the presence of a double embryo
seed. One double embryo seed will give rise to two separate
plants.
The ginseng roots are corpulent. They are composed
of a tap-root with two to five lateral roots. The roots
are light yellowish white in color. The plants are vigorous
in producing lateral roots. The growth and the shape of the
root also vary according to the age of the plants.
1.3.CHEMICAL STUDIES ON CONSTITUENTS OF GINSENG:
1.3.1. SAPONINS:
The dried roots and rhizomes of ginseng contain many
physiologically active constituents. Among these, saponin
is the major component which has been extensively studied.
A number of ginseng saponin glycosides have been
isolated from methanol extracts of ginseng roots and iden-
tified by Soviet workers( Elyakov et al, 1964 1965 1968).
These saponins are called panaxosides. In 1964, Elyakov
reported the successful isolation of saponin glycosides,
6panaxosides A, B, C, D, E, and F. According to their
structures, these six ginseng saponin glycosides are divided
into two groups. Panaxosides A, B, and C belong to one group
and yield a common non=sugar substance (aglycone) called
panaxatriol (.Structure I) after acid hydrolysis, while
panaxosides D, E, and F belong to another group that yields
panaxadiol (Structure II) after acid hydrolysis. None of
the six panaxosides contains identical sugars. Panaxoside A
consists of three molecules of glucose panaxoside B, two
glucoses and one rhamnose panaxoside C, three glucoses
and one rhamnose panaxoside D, four glucoses panaxoside E,
four glucoses and one arabinose and panaxoside F, six
glucoses (Elyakov et al, 1964).
Professors Fujita, Itokawa, and Shibata of Univer-
sity of Tokyo are the most eminent ginseng researchers. In
1962, they were able to isolate two types of new compounds
from the methanol extracts of ginseng: sapogenin (aglycone)
and pro-sapogenin( Fujita et al, 1962 Sapogenins are
normally obtained when the saponin mixtures are treated
with hot hydrochloric acid in methanol. It was later con-
firmed that the sapogenins thus obtained were not genuine
sapogenins (aglycones), but actually an acid hydrolysed
products of ginseng saponins. The structure of sapogenins
was identified as panaxadiol (Structure II)( Fujta et al
19 62 Shibata, Fujita and Itokawa, 1962 Shibata et Al,










8tually obtained when the mixture of ginseng saponins was
hydrolysed under mild conditions( 0.7% sulfuric acid in
methanol). The true sapogenin thus obtained by the Japanese
workers was called prosapogenin, and the chemical structure
of it was identified as protopanaxadiol (Structure III)
(Shibata et al, 1963c Tanaka et al, 1964).
Another sapogenin, panaxatriol (Structure I) was
also obtained, the structure has been confirmed, similarly,
to be an acid hydrolyzed product during isolation. The
genuine aglycone would be protopanaxatriol (.Structure IV)
(Shibata et al, 1965).
In 1974, Shibata and his collaborators(Sanada
et al, 1974a 1974b) successfully isolated 13 ginsenosides
from ginseng root extract. They are: Ro, Ra J Rbl). Rb2
Rc, Rd, Re, Rf, Rgl, Rg2, Rg3, Rhl, Rh2, The
ginsenosides from R0 to Rh correlate with the increasing
R f-values of the thin-layer chromatography. Nine of the
total 13 ginsenosides have been characterized, and their
stuctures have been established(. Sanada 'et *al, 1974a, 1974b)
Depending on the aglycone portion of the molcule, these
ginsenosides can be divided into three groups. Ginsenoside
R0 gives oleanolic acid(. aglycone), while ginsenosides
Ra, Rb, Rc, Rd give panaxadiol and ginsenosides Re Rf,
Rg and Rh give panaxatriol after acid hydrolysis.
Oleanolic acid (Structure V) is a pentacyclic, oleanane-













Structure V Oleanolic acid
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groups, on the other hand, are tetracyclic dammarane-type
triterpenes.
Besides sapogenins each of these ginsenosides
contains different sugar molecules, though they all have
monosaccharides, and glucose outnumbers arabinose and
rhamnose. Ginsenoside Ra (.equivalent to Panaxoside F)
carries 6 moles of glucoses ginsenoside Rbl carries 4
glucoses ginsenoside Rb2, 3 glucoses and 1 arabinose
ginsenoside RC, 3 glucoses and 1 arabinose ginsenoside
Rd, 3 glucoses ginsenoside Re (equivalent to panaxoside
B), 2 glucoses, and 1 rhamnose ginsenoside Rf, 2 glucoses
ginsenoside Rgl) 2 glucoses ginsenoside Rg2, 1 glucose
and 1 rhamnose ginsenoside R 0, 2 glucoses and glucuronic
acid(. Sanada et al, 1974a 1974b). Later, Rb3 was also
determined to have 3 glucoses and 1 xylose (Sanada and
Shoji, 1978), Rh1, 1 glucose (Yahara et* Al, 1979).
1.3.2. GINSENG OIL AND PHYTOSTEROL:'
Ginseng oil contains volatile oil panacene and
-elemene, and non-volatile oil panxynol. Phytosterols
extracted from Chinese ginseng is called stigmasterol, and
that from Korean ginseng is called -sitosterol (Hou, 1977).
1.3.3. SUGARS AND CARBOHYDRATES:
The aqueous extract of ginseng root contains many
dif f erent types of sugar or saccharides. Ginseng pectin,
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a crude polysaccharide, is also isolated from ginseng root
(Hou, 1977).
1.3.4. MISCELLANEOUS COMPOUNDS:
Other components such as organic acids, non-protein
nitrogenous substances, amino acid and peptides, vitamins,
minerals and trace elements and certain enzymes have also
been isolated and characterized (Hou, 1977).
1.4. PHARMACOLOGICAL STUDIES OF GINSENG:
During the past decades, a rather broad spectrum
of different pharmacological activities of ginseng has
been reported in Korea, Japan, China, Russia and Bulgaria.
With regard to the pharmacologically active principles of
ginseng one must distinguish investigations which have been
done with the total extract from such investigations in
which more or less purified fractions of the extract or
chemically defined individual constituents from ginseng
were used. The situation is further complicated by the fact
that not only extracts from ginseng roots, but also extracts
from other parts of the plant have been used. Furthermore
the composition of the total extract or individual fractions
may vary due to the species of ginseng, the place of origin,
methods of growth or culture, technique of extraction and
various other factors. Most pharmacological investigations
in the past have been performed with total extracts from
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ginseng roots. The following pharmacological or biological
activities are summarised from review articles published
one to two decades ago (Anon., 1977):
1. Ginseng extracts can increase the capacity for physical
work and intellectual performance.
2. Ginseng preparations administered during prolonged periods
are reported to accelerate recovery from diseases. In this
connection it is sometimes emphasized that ginseng pre-
parations do not show any unwanted side effects and that
they do not lead to tolerance.
3. Ginseng effects on the central nervous system are not
easy to interprete. In the early papers, tonifying and
stimulating as well as depressing effects on the central
nervous system were described.
4. Ginseng effect on the cardiovascular system was also
studied. The results were equivocal both hypertensive
and hypotensive effects were reported.
5. Gonadotropic actions of ginseng have been studied and
are less ambiguous.
6. Influences of ginseng on metabolic functions, particularly
on carbohydrate metabolism have been noticed. Ginseng was
reported to reduce blood glucose level.
7. Anti-inflammatory effect is also attributed to ginseng.
8. The "adaptogenic effect" of ginseng refers to an increase
of the reactivity under stress situations and is manifested
as increase of the defensive forces of the organism.
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Some of the activities mentioned above are
pharmacologically not very well defined and may involve
simultaneously several organ systems or functions of the
body or may encompass various types of pharmacological
actions. Sometimes the results reported are even contradic-
tory. It appears therefore necessary to try to analyse the
whole complex of ginseng activities regarding effects in
single organs, tissues and cells. Such an analysis would
be facilitated if it could be based on investigations with
chemically defined constituents. With regard to the large
number of chemical compounds with a diversity of structures
which have been detected in ginseng, opposite actions or
contradictory results are probably not surprising.
Based on these new approaches during the last
decade, the mysterious cloud surrounding the myth of ginseng
is finally beginning to get demystified and its intrinsic
biological effects are described in modern biomedical terms.
Most of the recognized pharmacological activities are
itemized below.
1.4. 1. EFFECT OF GINSENG ON CENTRAL NERVOUS SYSTEM:
In early publications stimulating as well as
depressing effects on the central nervous system were described
(Anon., 1977). This discrepancy is partly explained through
investigations using purified fractions of the extract. A
crude saponin fraciton from ginseng leaves was shown to exert
15
CNS-depressant, tranquilizing and analgesic action( Saito
et at.,1973). Simultaneously, it was found that a ginseng
neutral saponin fraction from the ginseng root could act on
the CNS too( Nabata et al.,1973). This neutral sapon-in
fraction contains Rbl Rb2, Rc, the CNS-depressant effect
of which was revealed by its inhibitory effects on spontaneous
and exploratory movements, as well as potentiation of hexo-
barbital effect. It was later revealed that it was ginsenoside
Rbl that exerted the CNS-depressant action and Rgl that
exhibited CNS-stimulating activity( Takagi, 1977).
1.4.2. EFFECT OF GINSENG ON CARDIOVASCULAR SYSTEM:
A similar ambiguous situation appeared with
ginseng effects on the cardiovascular system. A few years
ago it was shown that certain fractions from ginseng might
cause an increase of blood pressure while other fractions
exerted the opposite effect(. Anon., 1977). This discrepancy
was not explained until the work of Takagi et' al.(. 1972b).
They found that the ginseng neutral saponin fraction contain-
ing Rbl' Rb2, RC caused a fall in arterial blood pressure,
but it had no effect on heart rate and respiration. The
neutral saponins did not alter the characteristic response
to a series of stimuli, and the hypotensive response to the
saponin fraction was not eliminated by atropine, diphenhy-
dramine and propanolol. As this neutral saponin fraction
caused the fall of arterial blood pressure it was--suggested
16
to have ganglion blocking activity.
The saponin fraction containing Rg1 caused
the blood pressure to fall transiently, diminished the heart
rate and accelerated respiration( Takagi et al., 19 72b_).
The effect of ginseng on the isolated heart
was also studied. Both early( Anon., 1977) and recent
studies( Bae, 1978) showed that ginseng had an inotropic
effect on the isolated heart.
1.4.3. EFFECT OF GINSENG ON SEX HORMONES:
Less doubtful are sex hormone-like activities
of ginseng preparations. Some previous investigations have
furnished evidence for the occurence of sex hormone-like
compounds in ginseng. Gonadotropic effects was shown to be
exerted by sterolglycosides isolated from ginseng( Karzel,
1977), and by thin-layer chromatography, estrone, estradiol
and estriol were detected in the liposoluble fraction of
ginseng extract.
1.4.4. EFFECT OF GINSENG ON INTERMEDIARY METABOLISM:
1.4.4.1. SUGAR AND LIPID METABOLISM
With ginseng effects on the endocrine system
or with hormone like actions of ginseng, influences on meta-
bolic processes may be connected. During the last few years,
most of the works were devoted to this topic, particularly
to the potential effects on carbohydrate and lipid metabolism.
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In early publications antihyperglycemic
effects of ginseng have been reported (Anon., 1977).
Recently, Yokozawa et al.( Yokozawa et al., 1975 Yokozawa
and Oura, 1976) found that ginseng saponin-rich--fraction
could reduce blood glucose slightly. This decrease in blood
glucose was accompanied by a, significant decrease in liver
glycogen( Yokozawa et al., 1976). Simultaneously, hepatic
lipogenesis was also shown, but the lipogenic capacity of
epididymal adipose tissue was more sensitive than that of
the liver to a maximal dose of ginseng extract. Accumulation
of lipid in adipose tissue was observed. On the other hand,
lipogenesis by these tissues was markedly influenced by the
nutritional status of the animals. Fasting of the animals
resulted in the reduction of lipogenesis(_ Yokozawa and Oura,
1976). Upon refeeding, lipogenesis returned to normal level.
Summing up the sequential stimulating biological actions on
lipid and sugar metabolism as a result of a single dose of
ginseng extract in the rat, the authors suggested that ginseng
extract turned the metabolic flow in the direction of lipo-
genesis by the conversion of sugar, i.e. a transformation
from carbohydrate to lipid, and its translocation from liver
to adipose tissue. The phenomenon was further evidenced by
the increased activity of pyruvate kinase, the enzyme cata-
lyzing the last step of glycolysis, in rats treated with
ginseng( Yokozawa et al., 1979).
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1.4.4.2. CHOLESTEROL METABOLISM:
Ginseng was shown to stimulate the biosynthe-
sis of cholesterol in liver in vivo( Sakakibara et al.,
1975 Gommori et al., 1976). However, no stimulation could
be observed with in vitro liver slices( Gommori et al., 1976).
It seems possible that most of the ginsenosides would affect
the cholesterol synthesis not directly but through certain
intermediate pathways which might involve the action of some
hormones.
In the synthesis of cholesterol, the rate-
limiting step is the conversion of 3-hydroxy-3-methyl glutaryl
coenzyme A(. HMG-CoA) into mevalonate, which is catalyzed by
HMG-CoA reductase (.EC .1...1..1.34). It was found that ginseno-
side Rbl was associated with the increased activity of HMG-
CoA reductase Ikehara et al., 1978).
The excretion of injected 4-14C-cholesterol
into bile and feces was enhanced by crude ginseng extract
( Yamamoto,.1973). As suggested by the authors, the activity
of cholesterol 71 -hydroxylase, an enzyme for cholesterol
degradation, might be increased after ginseng treatment.
Since it was found that the activities of HMG-CoA reductase
and cholesterol 7 -hydroxylase had a similar diurnal rhythm
with the level of -corticosterone in plasma(. Cheitfetz,1968 ) ,
these enzymes were supposedly induced by corticosterone.




Another kind of potential metabolic activity
of ginseng preparations concerns the protein metabolism.
The stimulating effects of ginseng extract on--the liver---
nucleus, cytoplasm and serum protein were shown to occur in
sequential order. The first phenomenon observed was a stimu-
lation in the Mg -activated DNA-dependent RNA polymerase
activity(. Hiai et al., 1971). Then there was an increase
in the rate of liver nuclear RNA synthesis( Oura et al.,
1971). Substantial stimulation in the cytoplasmic polysomal
RNA synthesis followed, thus elevating the hepatic polysome
content and the protein synthetic activity( Oura et al.,
1972a). Finally, synthesis of serum protein was gradually
stimulated( Oura et al., 1972b). Serum protein synthesis
was later confirmed( Han et al., 1973 ).and the stimulating
action was due to ginseng saponin(_ Oura et al., 1975).
Based on these studies, it was suggested that the action of
ginseng extract exerted a stimulatory action on the RNA and
protein biosyntheses.
It has been known that the activity of RNA
polymerase is increased in liver nuclear preparation of
rats treated with cortisol( Litwack and Singer, 1972).
Therefore, it was assumed that an enhancement in the rate of
RNA and serum protein by ginseng extract might be due to the
elevated concentration of adrenocortical steroids. Such a
possibility was contradicted by some other observations.
20
It is a well-known fact that tryptophan pyrrolase and tyrosine
transaminase can be induced by corticosterone( Schimke and
Doyle. 1970 Litwack and Rosenfield, 1973), but the two
enzymes were not significantly affected by ginseng extract
( Oura et al., 1972). Therefore, at present, no definite
conclusion can be drawn.
1.4.5. ADAPTOGENIC EFFECT OF GINSENG:
A number of investigations performed during
the last decades aimed at demonstrating the adaptogenic
effects, of the ginseng preparations. It could be shown, for
example, that ginseng extracts increases-the duration of
running ability, or prolonged significantly the swimming
time of rats( Karzel, 1977).
It is of interest that some ginseng activities
are only demonstrable in stressed, impaired or injured
animals. Therefore, various types of experiments were
designed using animals submitted to biological, physical
or chemical damages. It could be shown that pretreatment
with ginseng saponin prolonged the time leading to clonic
and tonic extensor convulsions induced by pentylenetetrazol
and to death induced by strychnine( Nabata et al., 1973 ) .
Ginseng neutral saponins showed a significant antipyretic
activity in preventing the development of fever induced by
a pyrogen (Nabata et al., 1973). Significant inhibition
of writhing induced by acetic acid was exhibited by ginseng
21
neutral saponins( Takagi et al., 1972a Nabata et al., 1973)
and ginsenoside F from ginseng leaves( Saito et al.,1973).
Six methods were used in the study of ginseng root on reco-
very from exhaustion: Exploratory movement tests, hole cross
test, rotating rod test, sliding angle test, spring balance
test and rectal temperature test. Anti-fatique effects of
ginsenoside Rgl were obvious in every test while neutral
saponin fraction had no effect on recovery in the 6 tests
( Saito et al., 1974).
Some investigations dealed with protective
effects of ginseng against cold or heat exposure. Here again
usually no influence of ginseng on normal animals kept at
room temperature was demonstrable( Li and Li, 1973). Some
workers (..Sung and Chi, 1958) found that when control rats
were under stress at high temperature, they would be either
unable to move or show clonic convulsion. However, the
ginseng-treated rats were relatively normal when under stress.
Another parameter used to indicate protective ginseng effects
in animals under hyperthermic stress is the adrenal ascorbic
acid (-Sung and Chi,1958; Kim et al. 1970). In animals
under normal temperature conditions ginseng did not have any
effect on the adrenal ascorbic acid content. After exposure
to cold or heat, however, ginseng caused at firsta faster
decrease and subsequently a fast normalisation of the
adrenal ascorbic acid content, while in control animals, a
further decrease of the values occurred( Kim et al.,1970).
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These results indicate that ginseng facilitates the reaction
to and accelerates the recovery from temperature stress
by modulating adrenal steroidogenesis.
Similar antistress effects of ginseng prepa-
rations could in some cases be demonstrated in animals
under stress treated with the adrenocortical hormones.
This leads to the potential effects of
ginseng preparations on the endocrine systems or to homone-
like actions of ginseng itself. The question has been put
forward whether particularly the antistress activities
of ginseng, or other actions of ginseng preparations are
mediated via the adrenal cortex, or the adrenocortico-
pituitary system. Some findings seem to point out an
involvement of this system but others do not. It could be
shown for example, that ginseng extracts had a stimulating
action on glucocorticoid production, which was reflected
by the hypertrophy of the zona fasciculata at the border
of the zona reticularis(. Kim et al.', 1970) adrenalecto-
mized rats lost their ability to withstand temperature.
stress even under the influence of ginseng(_ Karzel, 1977).
However, in other experiments ginseng preparations exerted
antistress activities also in adrenalectomized mice( Karzel,
1977). Other effects of ginseng preparation, such as
stimulation of serum protein synthesis Oura et al., 1972 ) ,
reduction of blood glucose and glycogen content( Yokozawa
et al., 1975) could not be shown to be mediated through
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the adrenal glands. Nevertheless, a recent study of Hiai
et al. (1979) revealed a dose-response relationship between
ginseng saponin and rat plasma corticosterone level. A
% it
maximum increase of corticosterone was found at a saponin
dose of 8 mg/100 g body weight. This study has reinforced
the belief that ginseng stimulates the adrenocortical
system. The present work followed the same line of thought
and the ginseng effect on the pituitary-adrenal'axis was
therefore examined.
1.5. ADRENALCORTICAL HORMONES' GLUCOCORTICOIDS
1.5.1. PHYSIOLOGY
Adrenalcortical hormones are hormones
released from the adrenal cortex. These hormones fall into
2 groups: glucocorticoid and mineralcorticoid. The major
glucocorticoid components are cortisol and corticosterone.
The activity of the adrenal gland is under
the trophifc control of the pituitary`. In response to appro-
priate stimuli, the anterior pituitary secretes adrenocor-
ticotrophic hormone (ACTH) which in turn stimulates the
adrenal cortex to synthesize and release adrenal corticoids.
The reslease of ACTH is, in fact, controlled by another
trophic hormone, or set of hormones, called corticotropin-
releasing factor, or CRF( Saffran et al., 1955 Schally
et al., 1960). These hormones are discharged in the median
eminence and are carried to the anterior pituitary by a
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venous network called the pituitary portal system.
Essentially, the stimulated adrenal cortex
secretes adrenocortical hormones into the bloodstream.
About 307 glucocorticoids in blood circulates as free-----
steroid( Daughaday and Mariz, 1961). Of the remainder,
50% is bound to low affinity, high capacity carrier asso-
ciated with albumin and 20% to a high affinity, low capacity
globulin of 52,000 molecular weight called transcortin
or CBG (corticoid-binding globulin)( Westphal, 1971).
The unbound steroid is thought to be the biologically
active component of the system Thompson and Lippman, 1974).
The steroid-protein complex, in turn, may serve a buffer
capacity, supplying additional unbound steroid as either
free steroid is removed or as conditions change the binding
constants between steroid and protein. The steroid-protein
binding is markedly sensitive to temperature. Steroid-protein
binding in serum, for example, is decreased by increasing
temperature in and about the normal range( Pegg and Keane,
1969).
Release of ACTH from the pituitary and
response of the adrenal to ACTH is influenced by the level
of circulating corticoids(_ Sayers and Sayers, 1947).
There are two feedback mechanisms on stress-induced release
of ACTH namely, the level-sensitive and the rate-sensitive
control (_Smelik and Papaikonomou, 1973). In the level-
sensitive (delayed) control, inhibition of the system
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depends on the intensity of the stimulus and the level of
circulating glucocorticoid( Smelik and Papaikonomou, 1973).
For the fast rate-sensitive feedback( Dallman and Yates,
Hepends on the intensity of the stimulus and the level of
tional to the rate of rise of hormone concentration. As
the rate of rise of hormone concentration becomes small,
the effect progressively reduces and finally disappears.
1.5.2. EFFECTS OF GLUCOCORTICOIDS:
Glucocorticoids have a wide range of actions
on target tissues. These actions are thought to be of
restorative importance, permitting return of the organism
to homeostatic equilibrium.
The actions of glucocorticoids are remarkably
tissue specific and a set of changes produced in one tissue
may be quite opposite to those produced in another tissue.
Thus, in liver, adrenocortical hormones increase hepatic
urea formation (_Engel, 1950) as a result of rapid amino
acid catabolism, increase uptake of amino acids, increase
liver protein nitrogen( Clark, 1953) at the expense of
protein depletion of other tissues, and increase liver RNA
without changing DNA level(_ Silber and Porter, 1953).
The increase in hepatic protein following corticoid adminis-
tration is due, in part, to hormonal induction of a variety
of enzymes important in gluconeogenesis, glycolysis, urea
"Jones et al ,1974).the magnitude of the effect is propor-
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formation, and amino acid catabolism. Induction of these
enzymes is preceded by an increase in liver RNA nucleotidyl
transferase, increased RNA polymerase( Barnabei et al.,
c r
1966), increased RNA turnover, and an increase in the
absolute amount of RNA(. Feigelson et al., 1962).
Glucocorticoids strongly affect liver glucose metabolism
and indeed, such effects are perhaps primary to their
adaptive function. Glucocorticoids, in vitro, inhibit
glycogen formation by liver( Seckel, 1940). However,
in vivo this is overcome by gluconeogenesis both from
amino acids and compounds such as lactate, pyruvate, and
succinate Lewis et al., 1940).
What holds true for liver, however, is not
necessarily true for other tissues. While liver RNA and
protein concentration are increased by corticoids, RNA in
both thymus and spleen is decreased while protein is
decreased in thymus but not in spleen (Hofert and White,
1968 Abraham and Sekeris, 1971 ).The marked involution
of thymus and other lymphatic tissue upon glucocorticoid
treatment dramatically demonstrates the tissue selectivity
of corticoid actions. Involution of these tissues appears
to be due to a suppression of DNA synthesis and an inhibition
of mitosis Stevens-et al., 1965), resulting in marked
decrease in lymphocytes in the peripheral circulation
The number of circulating eosinophiles also declines
(_ Navarette and Petit, 1962), apparently owing to destruc-
27
tion of these cells in bone marrow( Greendyke- et al. ,1965).
On the other hand, polyrnorphonuclear neutrophils increase
( Nelson et al., 1952) despite depressed mitotic activity
( Cardinali et al., 1964), probably as a result of increased
cellular half-life.
Like aldosterone, glucocorticoids in small
doses reduce sodium excretion and increase potassium excre-
tion (.Ingle et al., 1946). They increase gastric secretion
and produce gastric ulcers(. Loeb and Sternschein, 1973).
Autonomic reactivity is potentiated, cardiac output is
increased, circulatory responses to epinephrine are
potentiated, and capillary resistance is increased( Yard
and Kadowitz, 1972). In addition, glucocorticoids inhibit
inflammatory reactions(. Dougherty et' al., 1973), a
property which has led to widespread therapeutic use. They
also inhibit antibody production, impair migration of
phagocytic cells and impair phagocytosis itself(. Balow
and Rosenthal, 1973). As might be expected from this
enumeration, resistance to infection is decreased.
Little is known about the direct effects of
adrenocortical hormones upon the brain itself, although
considerable clinical and experimental literature exists
on behavioral changes in adrenal malfunction. Adrenal
insufficiency in Addison's .disease is accompanied by behavioral
changes such as depression, apathy, instability, and appre-
hension, together with changes in EEG. The reverse case
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of adrenal hyperactivity in Cushing's disease is accompanied




s (1,2,6,7- 3 H)-Corticosterone was supplied by New
England Nuclear Corporation, specific activity 82.3Ci/mmole
Corticosterone for the standard was purchased from Sigma
Chemical Co., U.S.A.. Adrenocorticotrophin (Cortrophin Z)
was a product from N.V. Organon Oss, Holland. All chemicals
used were of analytical grade.
2.2. PHYTOCHEMISTRY OF GINSENG
2.2.1. PREPARATION OF A TOTAL GINSENG SAPONIN EXTRACT:
Three-year old untreated dry roots of Panax ig nseng-
C.A. Meyer_ were purchased from the herbal stores. It was
originated from South Korea. Total ginseng saponin fraction
was obtained according to the procedures of Sanada et al.
(1974).( Fig. 1).
Six hundred g of dry ginseng-root were blended into
small pieces in a Waring blender. The blended plant material
was then macerated in 21. of methanol overnight, and refluxed
with the same methanol at 600C for 4 hr. The reflux procedure
was repeated two times using a new portion of methanol. After
ref lux was completed, the hot methanol extracts were pooled,
filtered, and concentrated to dryness in a rotary evaporator
under reduced pressure at 50°C. The dried extract was dis-

















Fig.1 Extraction of total ginseng saponin
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with an equal volume of ether three times. The aqueous phase
was then partitioned with water-saturated n-butanol three
times. The butanol extracts were collected and concentrated
to dryness. This was the total saponin fraction used in the
experiments. Composition of this fraction was determined by
thin layer chromatography.
2.2.2. THIN-LAYER CHROMATOGRAPHY OF TOTAL GINSENG SAPONIN
FRACTION:
Saponin components were checked in the total
ginseng saponin fraction by thin-layer chromatography. It
was compared with the total saponin fraction obtained by
Professor U. Sankawa of Tokyo University. Analytical pre-
coated TLC plates, silica gel 60 F254, purchased from
Merck Chemicals were used. Two solvent systems were employed
according to Sanada et al. (1974):
(1) n-butanol:acetic acid :water (.4:1:2)
(2) chloroform:methanol :water (65:35-./,10)
Pure crytalline R9 used as the standard was a
gift from Professor U. Sankawa. The spots were detected by
spraying with 10% H2SO4 and heating on a hot plate.
2.3. THE PREPARATION OF CORTICOSTERONE-BINDING GLOBULIN
FOR-COMPETITIVE-PROTEIN-BINDING'-ASSAY:
2.3.1. PREPARATION OF CBG:
Female albino Sprague Dawley rats of 200-250 g
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were primed with estrogen 24 hr before sacrifice (single
injection, i.m., 100ug). Blood was collected from the dorsal
abdominal aorta. Blood samples were pooled together and
allowed to clot in refrigerator.-The serum so obtained--was
stripped to get rid of any corticosterone bound on the
binding protein. For the stripping procedure, serum was
incubated with charcoal (20 mg charcoal/ml serum) at 370C
shaking for 30 min. After incubation, the mixture was cen-
trifuged at 7,000 x g (Sorvall RC2-B) at 4C for 10 min.
The supernate was distributed into small test tubes so
that each tube contained 1 ml of serum sample.. They were lyophi-
lised and stored in a deep freezer. The dry serum was
reconstituted and diluted to appropriate concentration
with distilled water as the working solution.
2.3.2. DETERMINATION OF CBG TITER:
A fixed amount of tracer (40 nCi/ml corticoste-
rone) was incubated with the binder' (serum) obtained from
above at increasing times of dilution 10, 30, 100, 300,
and 1,000. The mixture was incubated first for 5 min at
450 C and then f or 20 min in ice bath. Then 0. 2 ml charcoal
suspension (1% charcoal and 0.1% dextran) was added to
separate the free and bound tracer, The mixture was centri-
fuged at 3,000 x g for 10 min, and the whole supernate was
decanted into a counting vial containing 10 ml Triton-toluene
scintillant (toluene 666 ml, Triton X-100 333 ml, PPO 5.5 g,
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POPOP 0. 1 g). Radioactivity was determined using the Beckman
LS-330 Liquid Scintillation System, completed with background
deduction and quenching control.
2.4. ANIMAL TREATMENT
Male rats of Sprague Dawley strain, weighing
160-190 g were housed in a light-controlled room (7:00-21:00
day cycle). They were fed with laboratory chow and water
ad libitum.
Rats were divided into experimental and control
groups. In the experimental group, animals were further
divided into 2 sub groups-namely chronic group and chronic-
acute group.
In the chronic group, animals were injected
intraperitoneally 0.5 ml ginseng saponin in saline (10 mg
total saponin fraction/ 100 g body weight) for 2 days.
Injections were made at 9:30 a.m. of each day. The rats
were sacrificed on the third day.'
For the chronic-acute group, the same treatment
as the former group was followed except that the animals
received one more injection on the third day morning one
hour before sacrifice.
The control group received exactly the same
treatment as the experimental groups except that the ginseng
saponin fraction was replaced by the same volume of saline.
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2.5. SAMPLE COLLECTION
Rats were sacrificed at 9:30-10:30 a.m. by
guillotine. Trunk blood was collected in test tubes. The
blood samples were allowed--to-clot in refrigerator-over-
night. Serum was separated and analysed for corticosterone
by'competitive protein binding assay according to the method
of Pegg and Keane (1969). In the exsanguinated rat, the
liver was perfused with cold isotonic saline via the hepatic
portal vein. Pituitary, hypothalamus, cerebrum and livers
were then removed. They were frozen immediately in liquid nitro-
gen and kept in a deep freezer. Pituitary, hypothalamus,
and cerebrum were for the assays of corticosterone content
which were done within 2 days, whereas the liver so collected
was to be used for the determination of corticosterone
binding capacity and affinity. The adrenal glands were also
removed, trimmed of fat and kept in Krebs-Ringer bicarbonate
solution (pH 7.4, 0,154 M NaCl, 0.154 M KC1, 0.11 M CaC12,
0.154 M KH2P04, 0.154 M MgSO4.7H20,/ 0.154 M NaHCO3,
containing glucose at 2 mg/ml) gassed with 95% 02+ 5% CO2
for 10 min at 37 C. Experiment on the adrenal response to
ACTH was done immediately.
2.6. SAMPLE PREPARATION
2.6.1. PITUITARY, HYPOTHALAMUS AND CEREBRUM:
The pituitary, hypothalamus and cerebrum were
homogenised with a Polytron type PCU-2 homogeniser in
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dicholoromethane (3 ml for pituitary and hypothalamus, 10 ml
for cerebrum). The tubes were kept in ice to prevent thermal
inactivation. Homogenisation was continued until all the
visible tissue particles were finely dispersed. The homo-
genate was then agitated on a Vortex mixer for 1 min and
centrifuged in a clinical centrifuge for about 3 min the
tissue disc was removed by water suction. One ml aliquot
of pituitary and hypothalamus extracts, and 3 ml of cerebrum
extract were removed and placed in 12 x 75 mm culture tubes.
They were dried at room temperature with a stream of nitro-
gen. The samples of pituitary, hypothalamus and cerebrum
were then ready for the competitive binding assay of
corticosterone.
2.6.2. SERUM:
A 0.2 ml aliquot of serum sample was added to
3 ml of dichloromethane and agitated on a Vortex mixer
for 1 min. The serum layer was aspirated off. One ml of the
organic layer was placed in a disposable culture tube and
dried with a stream of nitrogen at room temperature. The
serum sample was ready for the competitive protein binding
assay of corticosterone.
2.6.3. LIVER:
Three g of liver were minced and rinsed in
cold homogenization buffer solution (250 nM sucrose, 25 mM
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KC11 10 MM MgC12, 1 mM mercaptoethanol, in 50 mM Tris-HC1,
pH 7, 5). The minced tissue was homogenised in 6 ml buffer
with Polytron type PCU-2 homogeniser and centrifuged at
105,000 x g for 1 hr in a Beckman Model L5-50.-Ultracentri-
fuge at 4°C. The supernate was carefully removed and saved
for the corticosterone binding assays. Protein determina-
tion was made by the method of Lowry et al (1951).
2.7. ASSAY METHODS
2.7.1. ASSAYS OF CORTICOSTERONE IN PITUITARY, HYPOTHALAMUS,
CEREBRUM AND SERUM:
The content of corticosterone was estimated
by the method of Pegg and Keane (1969) with modifications.
The dried samples of pituitary, hypothalamus, cerebrum and
serum were dissolved in 0.5 ml of 2% ethanol in 0.9% saline.
The samples were agitated with a Vortex mixer to ensure
complete dissolution. The binding reagent was prepared
immediately before use by addition of 0.5 ml of tritiated
corticosterone solution (.4 uCi/ml) to 50 ml serum-CBG
solution. A series of 0.5 ml standards were set up at
concentrations 0.3, 1, 3, 10, 30 ng corticosterone/ml.
A 0.5 ml aliquot of the binding reagent was added to the
samples and standards. The tubes were shaken and warmed to
45°C for 5 min, then cooled in ice for at least 20 min.
Then 0.2 ml of a dextran-coated charcoal suspension was
added (1% aqueous suspension of Norit A from Serva, in 0.1%
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dextran,M.W. 80, 700) to separate bound and free steroid's. The
mixture was shaken and centrifuged immediately in Beckman
Model TJ-6 Centrifuge with Model TJ-R Refrigeration Unit,
at 3,000 x g 10 min. The whole supernate was decanted and
mixed with 10 ml of scintillation cocktail in a counting
vial. Radioactivity was determined using the Beckman LS-
330 Liquid Scintillation System as mentioned above.
2.7.2. DETERMINATION OF BINDING CAPACITY AND AFFINITY OF
THE BINDING PROTEIN IN LIVER:
The binding capacity and affinity were deter-
mined by the method of Pegg and Keane (1969) with slight
modifications. Stripped liver homogenates were studied.
Stripping was done by adding 0.2 ml charcoal suspension
(20 mg/ ml buffer) to 2 ml of liver homogenate. The
mixtures were allowed to stand at 370C for 15 min, and
then centrifuged at 7,000 x g for 10 min. The supernates
thus obtained will not contain the endogenous corticosterone
bound on the binding protein.
Ten ul of various concentration of 3H-cortico-
sterone were mixed with 0.2 ml of liver homogenate to give
a final concentration of 50, 25, 10, 5 ng corticosterone/ml.
The samples were mixed and incubated at 4°C for 3 hr. The
unbound steroid was adsorbed by addition of 0.1 ml dextran-
coated charcoal suspension (3.757 charcoal, 0.375%° dextran
38
in homogenisation buffer) and mixed, They were then centri.
fuged in a Beckman Model TJ-6 Centrifuge at 3,000 x g for
10 min. Then 0.1 ml supernates were counted in 10 ml of
scintillation cocktail. The total redioactivity in the
incubation mixture was determined by adding the homogeniza•
ton buffer instead of charcoal.
Non-specific binding was estimated by preparing
parallel solutions containing 500-fold excess of unlabeled
corticosterone, following the same procedures as above.
The difference in radioactivity( cpm) bound to cytosol
proteins in the absence and presence of the 500-fold
concentrated corticosterone solution was taken as an index
for the number of the high affinity saturable binding
sites for corticosterone.
2.7.3. DETERMINATION OF BINDING CAPACITY AND AFFINITY OF
CBG IN SERUM:
Stripped serum samples were prepared by mixing
2 ml of diluted serum with 20 mg of Norit A. The mixture
was incubated at 37°C for 30 min and then centrifuged at
7,000 x g for 10 min. The supernate containing the CBG
was free of endogenous corticosterone, Serum had been
diluted 5--fold with Tris buffer (0,05 M Tris-Cl, 0.1 M
NaCl, 0.1% NaN3 and 0.1% gelatin, pH 8.0). Ten ul of
various concentration of 3H-corticosterone were added to
0.2 ml of the serum samples to give a final concentration
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of 200, 100 1 50, 25, 10 ug/ml, The mixtures were allowed to
stand for 5 min at 450C and 5 min in ice bath. Then 0,lml
of dextran,coated charcoal suspension was added (3.757
charcoal, 0,375% dextran in Tris buffer)., The suspensions
were shaken, then allowed to stand for 10 min and centri-
fuged at about 3,000 x g for 10 min, Aliquots of the
supernates were counted.
Non-specific binding was estimated as in liver
homogenate. The difference between radioactivity measurements
with and without the excessive unlabeled steroid represented
the specifically bound corticosterone.
Both the binding capacity and binding affinity
were obtained from analyses using the Scatchard plot
(Scatchard, 1949).
2.7.4. EFFECT OF GINSENG SAPONIN ON ADRENAL RESPONSE TO
ACTH:
Pooled samples of adrenal. quarters obtained
from control and ginseng-treated rats were used. Two quar-
ters were taken in random as .a set and mixed with 1 ml of
Krebs-Ringer bicarbonate buffer, pH 7.4 containing 2 mg/ml
glucose in a polyethylene tube. The tube was gassed with
95% 02+ 5% CO2, then capped and incubated at 370C for
1 hr with gentle shaking. The incubation medium was decanted.
Another 1 ml aliquots containing 0, 0.01, 0.1, 1 U of ACTH
were added to the adrenal quarters and the procedure was
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repeated. The incubating solution from each set was removed
and assayed for corticosterone.
Corticosterone in the incubation medium was
assayed by the method of Zenker and=Bernstein (,.1958). The
incubation medium samples were shaken vigorously with 3 ml
of dichloromethane, and centrifuged at 3,000 x g for 2 min.
The upper layer (aqueous phase) was aspirated off. The lower
layer (CH2Cl2 phase) was then collected and shaken with an
equal volume of conc. H2SO4 in absolute ethanol (H2SO4:EtOH,
7:3) for at least 15 sec, After standing for 30 min, the
top layer of CH2Cl2was aspirated off, and the fluorescence
of the bottom layer was read in a Turner Model 430 spectro-
fluorometer (excitation 470 nm, emission 525 nm).
The standard curve was obtained by running
0--0,4 ug of corticosterone through the same procedure.
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3. RESULTS
3.1. CHARACTERISTICS OF TOTAL GINSENG SAPONIN FRACTION:
to
Thin-layer chromatography was employed in
characterizing the components of the total saponin fraction
obtained through the procedures as described in METHOD.
Pure R obtained from Professor U. Sankawa
g
was used as the standard. As shown in Fig. 2, the chromato-
grams of our saponin sample and that obtained from Professor
Sankawa showed a similar pattern. As the composition of the
two saponin fractions were almost identical, the results
obtained from the two sources were pooled.
3.2. CBG TITER:
A dilution curve was constructed in order to
choose the appropriate dilution of the working serum
/the binder.-
A series of diluted serum was prepared as stated
in METHOD. According to Chard (1978), the concentration
of binder sufficient to bind approximately 507 of the tracer
is suitable for doing binding assays. From Fig.3, it was
shown that a 1:300 dilution of the binder satisfied
this condition and was thus employed for all binding assays.
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n-Butanol- Acetic acid-Chloroform- Methanol -Water
65: 35:10, Upper layer 3 Water
( 4:1: 2 2
Fig. 2. Thin-layer chromatography of the total saponin













3 1 :10 1:30 1:100 1:300 1:1 1: 3CMDO
Plasma dilution
Fig. 3. A binder-dilution curve
%Bound
44
3.3. CORTICOSTERONE LEVELS IN SERUM, PITUITARY, HYPOTHALAMUS
AND CEREBRUM:
3.3.1. SERUM CORTICOSTERONE
As shown in Table-l it was observed-that the
ginseng-treated rats in the chronic-acute group showed an
increase in serum corticosterone level as compared with the
controls. The value was 1.6 fold higher in the treated group.
This increase was statistically significant (0.05 7P7 0.01).
However, such difference was not found in rats in the chronic
group. Since conditions of chronic-acute group differ only
from that of chronic group by one more injection of ginseng
saponin before sacrifice, it seems that this acute dose of
saponin could cause an increase in serum corticosterone.
This agreed with the finding of Hiai et al (1979) who showed
that the serum corticosterone level was increased in response
to a single injection of ginseng saponin in rats before
sacrifice.
In addition, the control animals in both groups
did not show any significant difference in their serum
corticosterone level although control animals in chronic-
acute group showed a slight increase.
3.3.2. CORTICOSTERONE IN PITUITARY
It is well established that pituitary is the
site of feedback control for the secretion of ACTH (De Kloet
and McEwen, 1976). Since ginseng saponin can increase the
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Table 1. Effect of ginseng saponin on corticosterone level in rat serum.










Chronic group and chronic-acute group were described in "METHOD".
Data are expressed in mean S.E.
Numbers in parentheses indicate the number of rats in each group.
n.s. means "not significant".
The difference between controls in both groups is insignificant (0.4P0.3).
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level of corticosterone in serum, it would be interesting
to determine the corticosterone level in the pituitary.
For rats in the chronic group, the ginseng
m,.
treatment did not produce any significant difference in
pituitary corticosterone level as compared with the control
(Table 2). However, in the chronic-acute group, the ginseng
treatment caused a 1.8 fold decrease in pituitary cortico-
sterone level. Such a decrease was statistically significant
(0.05' P 0.01). This was contradictory to the 1.6 fold
increase in serum corticosterone level under the same condi-
tion.
Comparing the control values of corticosterone
in Table 2, it was found that control in chronic-acute group
had a slightly increased level of corticosterone than the
control chronic group. This increase is not statistically
significant. The elevation may be a response to the increased
handling of the animals.
3.3.3. CORTICOSTERONE IN HYPOTHALAMUS
Corticosterone level in the hypothalamus was
also determined. As shown in Table 3, no difference of
corticosterone level was found in hypothalarais between control and
treated rats in the chronic group. This was similar to the
result in serum and pituitary.
However, for rats in chronic-acute group (Table
3), the difference between the ginseng-treated group and the
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Table 2, Effect of .ginsen saponin on corticosterone level in rat pituitary.




Treated 0,368+0.019 (6) n.s.
Chronic-acute group
Control 0,499+0,050 (9) 0.02>p>0.01
Treated 0,276+0,0 (10)
Chronic group and chronic-acute group were described in "METHODS".
Data are expressed in mean + S,E.
Numbers in parentheses indicate the number of rats in each group.
n.s. means :not significant".
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Chronic group and chronic--acute group were described in METHOD.
Data are expressed in mean+ S.E.
Numbers in parentheses indicate the number of rats in each group,
n.s. means "not significant."
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control was still insignificant. The corticosterone level
in the treated group remained the same in spite of the
elevated serum corticosterone level (Table 1).
3.3.4. CORTICOSTERONE IN CEREBRUM
In order to study the ginseng action in the
central nervous system, the corticosterone level in cerebrum
was also determined (Table 4). Similar to the serum findings,
there was no difference in cerebral corticosterone levels
between control and experimental animals in chronic group.
For rats in chronic-acute group, the ginseng treatment
caused a marked increase in cerebral corticosterone (0.0l
P 0.005). The 1.7 fold increase in cerebrum was equal in
magnitude to the 1.6 fold increase in serum corticosterone.
When comparing the corticosterone levels in
cerebrum of the two control groups in chronic and chronic-
acute group, the latter had a much higher corticosterone
level (0.05P,-0.02).
3.4. STEROIDOGENIC ACTIVITY OF ADRENALS:
In order to evaluate the effect of ginseng on
the adrenocortical system against stress, the adrenal
response to ACTH was studied in vitro. As shown in Fig.4a
and 4b, both control and treated groups had typical dose-
dependent response while adrenals of the ginseng-treated
rats had an enhanced response to ACTH. Both ginseng-treated
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Table 4, Effect of ginseng saponin on corticosterone level in rat CEREBRUM.










Chronic group and chronic-acute group were described in METHOD.
Data are expressed in mean+ S.E.
Numbers in parentheses indicate the number of rats in each group,


















Effect of ginseng saponin on the adrenal response toFig. 4a.
ACTH in rats in chronic group.
The open circles represent the ginseng-treated rats,
the dark circles are for the control rats.
Each value represents Mean+ S. E.






















Fig. 4b.Effect of ginseng saponin on the adrenal response to
ACTH in rats in chronic-acute group.
The open circles represent the ginseng-treated rats,
the dark circles are for the control rats.
Each value represents Mean+ S.E.








chronic and chronic-acute groups showed the difference which
was already distinct at fairly low doses of ACTH.
In the chronic group, the response was 1.3 fold
greater in the treated groups when 0.01 and 0.1 U of ACTH
were used (Fig. 4a). However, when 1 U of ACTH was used,
the response between control and treated groups did not
show any significant difference. This is probably the result
of a supramaximal response.
In the chronic-acute group, the response was
more than 1.2 fold higher in adrenal samples from ginseng
treated rats (Fig. 4b). Although at the dose 0.1 U of ACTH,
the difference in corticosterone release between control
and treated group was not significant, the trend of increa-
sing response could still be observed.
3.5. BINDING CAPACITY OF LIVER BINDING PROTEIN:
In the investigation of the binding capacity
of the binding protein in rat liver,/the total corticosterone
binding protein was regarded, as the whole homogenate was
estimated without any fractionation before assay.
As shown in Table 5, the binding capacity was
higher in the ginseng-treated rats in both chronic group
and chronic-acute group. It could be noted that the increase
in chronic group was 1.9 fold and the difference was signi-
ficant. The increase in chronic-acute group was 1.7 fold,
but for the large standard error in the treated group, the
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Treated 10.12+2.23 (7) n.s.
Chronic group and chronic-acute group were described in "METHOD".
Data are expressed in mean + S.E,
Numbers in parentheses indicate the number of rats in each group
n.s. means "not significant".
Experimental group Binding vapacity Statistical
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difference between the treated and the control would not be
significant, Nevertheless, the trend of increase was still
apparent.
It should be noted--that the--control-animals in
chronic group and chronicacute group had almost the same binding
capacity also the value obtained from the treated chronic
group was close to that in the treated chronic-acute group.
The binding affinity was the same for control
and treated animals in both groups. A value of (1.77+0.42)x
107 M 1 was obtained.
3.6. BINDING CAPACITY OF SERUM CBG:
As shown in Table 6, there was no change in
binding capacity of serum CBG in the ginseng-treated animals
in both groups, indicating the concentration of CBG in serum
was not increased after ginseng treatment. The binding
affinity of serum CBG was similar for all groups. The
association constant found was (1.17+,0.32) x 107 M-1
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TabLle 6, Effect of ginseng saponin on binding capacity of serum CBG.
Experimental group Binding capacity Statistical









Chronic group and chronic-acute group were described in "METHOD".
Data are expressed in mean+ S.E.
Numbers in parentheses indicate the number of rats in each group
n.s. means not "not significant",
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4. DISCUSSION
4.1. CHOICE OF GINSENG SAMPLE:
Total ginseng saponin fraction was used in
treating rats in every test. A total crude aqueous extract
of ginseng had been tried but results were equivocal. Since
the concensus of international literatures agree that the
bioactive component in ginseng is saponin, total saponin
fraction was used instead of total crude extract. It was
noted that the effect of total saponin fraction is more
consistent than that of the crude extract.
4.2. APPLICATION OF METHODS:
4.2.1. WAY OF SACRIFICE
Decapitation was chosen as the way of sacri-
fice for the rats because it is the quickest way to kill
the animal. It has been found that (De Kloet and McEwen,
1976) ACTH.secretion following a noxious stimulus is maximal
within 2 min, with maximal corticosterone concentration
observed after 15 min. Generally, basal rat plasma cortico-
sterone level is 13.0 1.2 ug/100 ml plasma under ether
stress, the plasma corticosterone level rises to
32.1 1.2 ug/ 100 ml plasma in two min (Feldman, 1974).
Therefore ether anesthesis was not used in sacrifice in
case the high level of corticosterone would mask the effect
of ginseng saponin.
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The corticosterone secretion following a
stressful stimulus (such as handling) applied during the
diurnal trough peaks at 5 min after application and then
falls rapidly. When applied during diurnal crest, the same
stimulus caused a much slower adrenocortical activation,
reaches a maximum after 30 min, and decreases slowly (Alder
and Friedman, 1968). However, if decapitation is the way
of sacrifice, the animal will die before the adrenals can
manage to release corticosterone.
4.2,2. TIME OF SACRIFICE
The time chosen for sacrifice of rats was
9:00 to 10:00 in the morning. This time interval is within
the range in which the corticosterone level is the lowest
in the circadian rhythm of the day (Stevens et al., 1973).
If the animal is sacrificed by the time when the corticos-
terone reaches a peak, then the effect of ginseng on the
corticosterone level will be mitigated. Moreover, the
corticosterone level between 8:00 and 12:00 a.m. is a
plateau, hence less fluctuation is encountered.
4.2.3. CBG AS A BINDER
Serum CBG was applied as a binder in the
competitive protein binding assay because it possesses a
number of advantages (Murphy, 1971). Firstly it is easiest
to obtain and prepare. Usually one needs merely to obtain
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blood by venipuncture, centrifuge it to obtain serum, and
dilute the serum to an appropriate concentration. Secondly,
it is very stable. If it is stored frozen in deep freezer,
it keeps for years, and if it is refrigerated, it keeps for
three weeks or often much longer. One big advantage of the
naturally-occuring proteins over antibodies to hormone
conjugates is the stability within a given species. With
antibodies, even from the same animal, the titer and speci-
ficity of every batch is different. As for CBG, its proper-
ties within any given species are consistent so that data
about its binding properties are comparable from experiment
to experiment.
4.2.4. TITER OF CBG
In the competitive protein binding assay, a
1:300 dilution of the binder (serum CBG) was employed and
an appropriate amount (.50%) of the tracer was bound at
such dilution (Fig. 3). In other studies (Pegg and Keane,
1969 Gould and Siegel, 1978), a 25-fold dilution of the
binder was employed. It may be due to the fact that the
binder used in the present experiment was obtained from
female rats primed with estrogen one day before the blood
was collected. It is a well established fact that the CBG
binding capacity of female rats treated in this manner is
much higher than normal male rats without treatment(: West-
nhal.1971). Therefore it can be reasoned that the CBG
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obtained in this way has a titer much higher than those
obtained without estrogen pretreatment
4.3. ACUTE AND CHRONIC EFFECT OF GINSENG SAPONIN ON THE
ORGANISM:
From previous studies, protein synthesis in
liver (Han et al., 1973) and serum (Oura et al., 1972) had
a slight increase after an acute dose of ginseng saponin.
Such an acute dose could also increase the serum corticos-
terone level in rats (Hiai et al., 1979). The chronic effect
of ginseng has not been tested. Traditionally people used
to take ginseng over a prolonged period of time. This
indicates that ginseng should have a longterm effect. The
question whether chronic doses of ginseng could have more
contribution is considered in this study.
In the present study, the chronic effect of
ginseng was investigated by treating the experimental
animals with 2 doses of ginseng with the last dose given
at 24 hours before sacrifice (the chronic group). It was
found that the serum corticosterone was not increased under
such treatment. Also, pituitary, hypothalamus and cerebrum
had no change in corticosterone level too. However, the
steroidogenic activity of the adrenal was enhanced and the
binding capacity of the liver binding protein was increased.
while the experimental animals were treated
as above but with one more injection one hour before sacri-
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f ice (the chronic-acute group), all the parameters showed
appropriate changes, the serum and cerebrum showed an
increased level of corticosterone, the pituitary showed a
decreased corticosterone level, the adrenals showed a better
response, and the binding capacity of liver binding protein
was augmented.
From the data obtained, it can be deduced
that ginseng effect on serum corticosterone level is acute.
This is good for sudden, unexpected severe stress, in
which case ginseng may immediately serve as an anti-stress
agent.
While the acute effect of ginseng can be
demonstrated by the serum corticosterone level, the chronic
effect of ginseng can be revealed from the steroidogenic
activity and the binding capacity of the liver binding
protein.
As mentioned above, the adrenals of both
treated groups (chronic group and chronic-acute group) had
a better response to ACTH than the control groups. This
finding is consistent with the work of Kim et al. (1970)
who found that the adrenal ascorbic acid depletion in
response to ACTH was faster in the rats treated with ginseng
than the control. It should also be noted that one more
injection before sacrifice did not cause any additional
difference in the response of the adrenals to ACTH. This
shows that ginseng is unable to produce these changes in
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one hour but these effects can persist for quite a long
period of time.
Another support to the chronic effect of
ginseng saponin is evidenced by the increased binding
capacity of the corticosterone binding proteins in liver.
In the present study, the whole liver cytosol was tested
and individual binding proteins were not separated.
According to literatures, there are at least seven binding
proteins present in the liver (Beato' et al.,1972a 1972b
Beato and Feigelson, 1972a 1972b Litwack et al., 1973
19.75 Feigelson et al., 1978). It is impossible to conclude
which binding protein has been increased after ginseng treat-
ment. Nevertheless, it is certain that the binding proteins
tested do not include binder I and binder III found by
Litwack et al,(.1973), because the ligand used in the assay
was tritiated corticosterone and not its metabolites. Binder
I and binder III bind the metabolites of corticosterone.
Also, the.binding proteins tested probably do not contain
protein G as found by Beato et' al (1972b) because this
protein is very labile. Therefore the liver homogenate
tested in the present study may contain transcortin, protein
B (Beato and Feigelson, 1972a), Binder II (Litwack et al.,
1973), and binder IB (Litwack et al., 1975). Since at the
present moment, the exact role played by each binding
protein is still unknown, it is not attempted to check
which type(s) of protein were involved.
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The present results show that the binding
capacity of the binding protein in liver is higher in the
ginseng-treated rats in both chronic and chronic-acute
groups without any change in binding affinity. This increase
in capacity might be due to de novo synthesis of more
binding proteins, as it is well established that ginseng
stimulates liver protein synthesis (Han et al,, 1973). As
it has been reported, the anabolic effect of corticosterone
can be demonstrated in terms of the enhanced de novo
synthesis of a small group of inducible enzymes (Schimke
and Doyle, 1970), these inducible enzymes function mainly
in the catabolism of amino acids and are typified by tyrosine
aminotransferase and tryptophan oxygenase (Litwack and
Rosenfield, 1973). According to our preliminary observation,
the increase in binding protein might also be involved in
slight change in enzyme activity of tyrosine aminotransferase
and tryptophan oxygenase. However, the information at hand
is too limited to afford any conclusion.
4.4. EFFECT OF GINSENG SAPONIN ON SERUM CORTICOSTERONE:
From the present data, there was no obser-
vable change in serum corticosterone in rats sacrificed
24 hours after the last injection. For rats following the
same schedule but treated with one more dose of ginseng
saponin just one hour before sacrifice, significant increase
of serum corticosterone level was found. This implicates
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that ginseng saponin can only cause a transient increase of
corticosterone concentration in serum that will not persist
at the elevated level for up to 24 hours. In normal rats,
there is a diurnal variation in serum corticosterone
throughout the day (Stevens at al 1973). This increased
level caused by ginseng saponin is almost comparable to
the peak value of the diurnal rhythm, which is still within
the physiological range. However, it seems that rats do not
maintain such a high level of corticosterone for longer
periods of times, as demonstrated from the data in the
chronic group, otherwise they might suffer from hyper-
corticosteronism.
It was also found that the serum .level of
corticosterone binding globulin (CBG) did not show any
change following the administration of ginseng saponin
(Table 6). Therefore, majority of the increased cortico-
sterone will be in free form rather than being bound to
globulin. Since the free corticosterone has a half life
of about 20 minutes (Schapiro et 'al., 1971), it is not
surprising to expect the fall of corticosterone level
after a few hours unless the adrenals sustain an increased
output of corticosterone. But in this case, the body will
suffer from hypercorticosteronism, such a phenomenon
caused by ginseng has never been reported in previous
literatures. But recently, adverse effects due to abused
use of ginseng preparations are known to occur. Hence,
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the assumption that ginseng only causes a transient increase
of corticosterone seems to be plausible. Moreover, rats
receiving 4 daily doses of ginseng saponin and sacrificed
on the fifth day have no-increase in serum corticosterone
(data not presented). However, more experiments should be
carried out to see how the serum corticosterone declines
after the rise in response to an acute adminstration of
ginseng saponin.
4.5. EFFECT OF GINSENG SAPONIN ON CBG:
It is well established that the serum
proteins are synthesized in liver (Westphal, 1971) and
released into the plasma. From the data of the liver
binding protein (Table 5), there is an increase in the
binding capacity, indicating that the protein content is
increased in the liver. But according to the data of the
serum CBG (Table 6), there is no change in the binding
capacity. Therefore the increased protein in the liver
may not be an=.increase in absolute amount of transcortin,
it may be an indication of the increased turnover rate
of CBG.
From another point of view, CBG increase
may not be necessary if the assumption that serum cortico-
sterone level only shows a transient increase is correct.
It has been reported that CBG bound corticosterone is
biologically inactive (Thompson and Lippman, 1974).
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Therefore, if the serum corticosterone remains unchanged
and serum CBG is increased, then the available free corti-
costerone will be decreased relatively. This will not
benefit the-regulatory system of-the organism
4.6. EFFECT OF GINSENG SAPONIN ON PITUITARY CORTICOSTERONE:
From the present data, a reciprocal relation
is found between the serum corticosterone level and
pituitary corticosterone level. The result shows that as
the serum corticosterone increases, there is a decrease in
pituitary corticosterone. This is not consistent with
the usuall feedback mechanism (Ganong, 1978). The discre-
pancy can be explained by assuming that the ginseng sapo-
nin may possibly compete with corticosterone for the
binding sites on the pituitary, so that pituitary cortico-
sterone is displaced by the ginseng saponin. Although
preliminary.experiments showed that ginseng saponin did
not compete with corticosterone for the binding sites on
pituitary in vitro (data not presented), this may be due
to the fact that the saponin fraction used in the experi-
ment was not pure enough. Competitive protein binding
experiment using isolated saponin was not attempted.
Therefore, the possibility of a displacement at the
pituitary level always exists,
As a matter of fact, the decrease in pitui-
r_arv corticosterone level in turn can stimulate the release
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of CRF from hypothalamus, the CRF is transported by the
portal vessels to the anterior pituitary (McCann and Porter,
1969 Ganong, 1977). Special cells in the anterior
pituitary release ACTH into the vascular system and ACTH
stimulates subsequently adrenal glucocorticoid secretion,
which will result in a better response of adrenal to
stimulus. Taken together, the decrease in pituitary corti-
costerone level, the better adrenal response to ACTH
challenge, and the increase in liver corticosterone binding
protein favor the synthesis and release of glucocorticoid
and are thus helpful to the body to resist stress.
4.7. EFFECT OF GINSENG SAPONIN ON HYPOTHALAMUS CORTICOSTE-
RONE:
In the late 1960's, it was accepted that
the localization of glucocorticoid receptors is mainly in
the hypothalamic area, where the CRF is stored( Chowers et
al., 1963 .Corbin et al., 1965). Ele6trical or mechanical
stimulation of the hypothalamic area results in the discharge
of ACTH, while lesions can practically inhibit the ACTH
secretion Mangili et al., 1966). The binding of cortico-
sterone in the hypothalamic region is thought to be related
to the role of these hormones in negative feedback mechanisms
involved in the regulation of ACTH secretion( Ganong and
Hume, 1954). Other studies show that destruction or removal
of the hypothalamus does not interfere with the feedback
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control of ACTH release( De Wield et al., 1964; Kendall
et at., 1964). These show that the hypothalamus may or may
not be essential for the feedback action, at least in the
suppression of stress-induced ACTH-release by supraphysio-
logical levels of glucocorticoids. However, studies of
3H-corticosterone distribution in the brain reveal that
there is a distinct regional difference in the uptake of
the radioactive steroid. The highest uptake is, however,
not observed in the hypothalamus (McEwen et 'al., 1972
Knizley, 1972).
In the present study, the results show
that ginseng saponin has no effect on the hypothalamus
corticosterone level both in the chronic group and the
chronic-acute group, in spite of an increase in serum
corticosterone level of up to 25 ug/100 ml. It can be
deduced from the above investigations that hypothalamus
may not be closely involved in the feedback mechanism.
Nevertheless, for the time being, it is too premature to
conclude that the hypothalamus is not a site of action
of ginseng saponin. Furthermore, since the hypotha3amus
is not a well-defined area in the brain, there is a possi-
bility that there might be some experimental error in
obtaining the exact anatomic region every time. Additional
studies will be required for confirmation.
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4.8. EFFECT OF GINSENG ON CEREBRUM CORTICOSTERONE:
In the cerebrum, when the chronic control
group is compared to the chronic-acute control group, a
significant increase in the corticosterone level in the
chronic-acute group is observed. This increase may somehow
arise from both handling and injection, which can cause
an increase in corticosterone release from the adrenals
and bound to the cerebrum.
In a study of diurnal variations in brain
capacity, it was found by Stevens et al. (1973) that the
amount of 3H-corticosterone bound by brain protein was
inversely proportional to the circulating level of corti-
costerone. This substantiates an earlier report( McCann
and Porter, 1969) that increased adrenocortical secretion
leads to an increase in the amount of corticosterone
that can be extracted from the brain. Therefore in the
present study, it is quite logical to find a parallel
increase in cerebrum corticosterone' level corresponding
to the elevated serum corticosterone level in the chronic-
acute group.
In the cerebrum, the hippocampus is respon-
sible for most of the corticosterone binding, Studies of
3H-corticosterone distribution in the brain reveal that
the highest uptake is observed in the hippocampus( McEwen
et al,, 1969 1972b Knizley, 1972). The largest amount of
binding protein is also found in the hippocampus( McEwen
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et' al., 1972a) and it has therefore the highest binding
capacity.
The physiological roles of corticosterone
in the hippocampus have_ been studied. It is found that
stimulation of hippocampus provokes the blockade of ACTH
release under basal and stress conditions( Mangili et al.,
1966 Kawakami et al., 1968). Along with serveral other
brain regions, the hippocampus has been shown to be a
target area for subtle effects of corticoids on ACTH
secretion. These subtle effects involve elevations or
reductions of basal levels of plasma corticosterone without
necessarily blocking ACTH secretion (De kloet and McEwen,
1976). Therefore, the increased corticosterone level in
cerebrum( the site of action is regarded to be the hippo-
campus) of the treated rats may contribute to the inhi-
bition of the corticosterone release. Whether some of
these effects may involve indirect actions via interaction
of corticosterone with receptors in hippocampus, septum
and amygdala remains to be investigated( McEwen et al.,
1972 De Kloet and McEwen, 1976).
It is reported that the increased corticos-
terone in the hippocampus is said to have important effects
on neural processes underlying behavior in rats( Bohus,
1973). It will not be surprising to find that such an
increase is also related to the emotional and vegetative
responses of the organism. However, whether ginseng has
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any interrelationship with these effects will require
more investigations,
4.9. GENERAL DISCUSSION:
Stress is a very complicated physiological
reaction, Upon stress, the regulating system may involve
co-operation of various hormones, among which, glucocor-
ticoids play the decisive role. Mortality in experimental
animals suffering from severe stress is obvious. Animal
studies have revealed that ginseng can reduce mortality
of the rats exposed to stress (Karzel, 1977 Anon., 1977).
From previous studies, ginseng was shown
to increase 17-ketosteroids in urine( Petkov and Staneva-
Stoicheva, 1965). It could also facilitate the depletion
and recovery of ascorbic acid in the adrenal( Kim et al.,
1970). The above phenomena are confirmed in the present
study by testing the corticosterone in serum directly.
Reduced. amount in the pituitary suggests that short loop
inhibition of ACTH release is removed. These two parameters
are not affected when injection of ginseng is given 24
hours ago. This may indicate a transient increase of
corticosterone after ginseng administration and may reflect
an acute effect of ginseng, The long-termed effect of
ginseng is demonstrated in the increase of liver binding
proteins as well as the augmentation of steroidogenesis
upon ACTH stimulation with or without pre-sacrifice ginseng
injection. In the light of these observations, ginseng may 
possess both acute and chronic function, at least in this 
particular site of action. Influence of ginseng on the 
corticosterone ~conteht_Tn~ the central'" nervous ^system may 
involve modification of behavior. Studies on this topic, 
although recurrent, are still ambiguous and uncertain.
The precise manner in which ginseng saponin 
can regulate the body and protect it against stress may 
well be complex. It is therefore unwise to draw far-reaching 
conclusion from the limited data presented here. The 
increased glucocorticoid level that accompanies stress is 
sure to play an essential role in survival. To what extent 
the biological effect of ginseng is acted through glucocor­
ticoid is difficult to quantitate. Hypophysectomy and 
adrenalectomy seem to be the next logical step in the study 
of ginseng effect on pituitary-adrenal axis. The long-termed 
effect of ginseng on the kinetics of circulating corticos­
terone level throughout the diurnal7 rhythm awaits further 
examination. Investigations using individual saponin compo­
nents will definitely give more meaningful answers.
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5. SUMMARY
1. Rats were divided into chronic group and chronic-acute
group. Ginseng-saponin-fraction was-shown to exert no effect on
But a 1.6 fold increase in serum corticosterone was found
in the ginseng treated chronic-acute group. This may
indicate a transient increase of serum corticosterone
after acute. ginseng treatment.
2, The pituitary corticosterone level was the same in control
and ginseng-treated chronic group, while a 1.8 fold
decrease in corticosterone level was shown by the ginseng
treated chronic-acute group. This will lead to an increase
in the release of corticosterone in the adrenals.
3. The hypothalamic corticosterone level was not affected
in all ginseng-treated groups,
4. Ginseng chronic treatment did not affect the cerebrum
corticosterone level. However, parallel to the serum
corticosterone, a 1.7 fold increase in cerebrum cortico-
sterone was exhibited by chronic-acute ginseng treatment.
5. The steroidogenic activity of the adrenals under the
stimulus of ACTH was enhanced in both ginseng-treated
chronic and chronic=acute groups, indicating the long-
termed effect of ginseng on the organism,
6. The capacity of the liver binding proteins was increased
in both ginseng treated-groups, indicating the-increased
effect on serum corticosterone level of the chronic group.
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concentration of binding proteins. The exact type of
binding protein was not determined. The binding affinity
was the same for control and treated animals in all
groups.
7. The capacity of serum CBG was the same for control
and ginseng-treated animals in chronic and chronic-acute
group. The binding affinity did not show any change in
all animals.
8. The acute effect of ginseng could be demonstrated by the
increased serum corticosterone level, while the long-
termed effect of ginseng could be exhibited by the
enhanced steroidogenic activity in the adrenals and
the increased binding capacity of liver binding proteins.
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